Consistent Revenue Growth
Seventh consecutive period of mid-single-digit revenue growth with over $92 million in total revenue, driven by a 15% year-over-year unit growth.
Strong International B2B Performance
International B2B achieved 19% year-over-year growth, driven by expanding into high opportunity global markets.
Adjusted EBITDA Profitability
Third consecutive quarter of adjusted EBITDA profitability with $2.3 million, highlighting consistent execution.
Voxi 5 Product Launch
Successful launch of the Voxi 5, a new stationary oxygen concentrator, with positive early market reception.
Positive Operating Cash Flow
Generated positive operating cash flow of $2.2 million or $4.6 million excluding one-time legal and settlement expenses.